186 related articles for article (PubMed ID: 30355785)
1. Distinct Roles for CD4
Bunn PT; Montes de Oca M; de Labastida Rivera F; Kumar R; Ng SS; Edwards CL; Faleiro RJ; Sheel M; Amante FH; Frame TCM; Muller W; Haque A; Uzonna JE; Hill GR; Engwerda CR
J Immunol; 2018 Dec; 201(11):3362-3372. PubMed ID: 30355785
[TBL] [Abstract][Full Text] [Related]
2. Induction of IL-10 and TGFβ from CD4+CD25+FoxP3+ T Cells Correlates with Parasite Load in Indian Kala-azar Patients Infected with Leishmania donovani.
Bhattacharya P; Ghosh S; Ejazi SA; Rahaman M; Pandey K; Ravi Das VN; Das P; Goswami RP; Saha B; Ali N
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004422. PubMed ID: 26829554
[TBL] [Abstract][Full Text] [Related]
3. Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis.
Nylén S; Maurya R; Eidsmo L; Manandhar KD; Sundar S; Sacks D
J Exp Med; 2007 Apr; 204(4):805-17. PubMed ID: 17389235
[TBL] [Abstract][Full Text] [Related]
4. Identification of regulatory T cells during experimental Leishmania infantum infection.
Rodrigues OR; Marques C; Soares-Clemente M; Ferronha MH; Santos-Gomes GM
Immunobiology; 2009; 214(2):101-11. PubMed ID: 19167988
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulation of host-protective immune response by regulating Foxp3 expression and Treg function in Leishmania-infected BALB/c mice: critical role of IRF1.
Chowdhury BP; Das S; Majumder S; Halder K; Ghosh S; Biswas S; Bandyopadhyay S; Majumdar S
Pathog Dis; 2015 Nov; 73(8):ftv063. PubMed ID: 26297915
[TBL] [Abstract][Full Text] [Related]
6. Involvement of CD4⁺ Foxp3⁺ regulatory T cells in persistence of Leishmania donovani in the liver of alymphoplastic aly/aly mice.
Tiwananthagorn S; Iwabuchi K; Ato M; Sakurai T; Kato H; Katakura K
PLoS Negl Trop Dis; 2012; 6(8):e1798. PubMed ID: 22928057
[TBL] [Abstract][Full Text] [Related]
7. CD4+FOXP3+ cells produce IL-10 in the spleens of dogs with visceral leishmaniasis.
Silva KL; de Andrade MM; Melo LM; Perosso J; Vasconcelos RO; Munari DP; Lima VM
Vet Parasitol; 2014 May; 202(3-4):313-8. PubMed ID: 24703254
[TBL] [Abstract][Full Text] [Related]
8. T cell suppression in the bone marrow of visceral leishmaniasis patients: impact of parasite load.
Kumar P; Misra P; Thakur CP; Saurabh A; Rishi N; Mitra DK
Clin Exp Immunol; 2018 Mar; 191(3):318-327. PubMed ID: 29058314
[TBL] [Abstract][Full Text] [Related]
9. CXCL10 treatment promotes reduction of IL-10
Eufrásio de Figueiredo WM; Heredia FF; Santos AS; da Rocha Braga R; Marciano Fonseca FR; Lúcia de Castro Rodrigues N; Abreu TM; Maria de Lima Pompeu M; Barbosa HS; Teixeira MJ
Exp Parasitol; 2019 Dec; 207():107789. PubMed ID: 31669169
[TBL] [Abstract][Full Text] [Related]
10. IL-33/ST2 axis is involved in disease progression in the spleen during Leishmania donovani infection.
Lamberet A; Rostan O; Dion S; Jan A; Guegan H; Manuel C; Samson M; Gangneux JP; Robert-Gangneux F
Parasit Vectors; 2020 Jun; 13(1):320. PubMed ID: 32571430
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic glucocorticoid-induced TNF receptor-mediated amplification of CD4+ T cell responses enhances antiparasitic immunity.
Haque A; Stanley AC; Amante FH; Rivera Fde L; Zhou Y; Kuns RD; Yardley V; Sakaguchi S; Hill GR; Engwerda CR
J Immunol; 2010 Mar; 184(5):2583-92. PubMed ID: 20139272
[TBL] [Abstract][Full Text] [Related]
12. Combined Immune Therapy for the Treatment of Visceral Leishmaniasis.
Faleiro RJ; Kumar R; Bunn PT; Singh N; Chauhan SB; Sheel M; Amante FH; Montes de Oca M; Edwards CL; Ng SS; Best SE; Haque A; Beattie L; Hafner LM; Sacks D; Nylen S; Sundar S; Engwerda CR
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004415. PubMed ID: 26872334
[TBL] [Abstract][Full Text] [Related]
13. Centrin-Deleted
Singh RK; Gannavaram S; Ismail N; Kaul A; Gedda MR; Nakhasi HL
Front Immunol; 2018; 9():1176. PubMed ID: 29915577
[TBL] [Abstract][Full Text] [Related]
14. Modulation of CD11C+ splenic dendritic cell functions in murine visceral leishmaniasis: correlation with parasite replication in the spleen.
Basu A; Chakrabarti G; Saha A; Bandyopadhyay S
Immunology; 2000 Feb; 99(2):305-13. PubMed ID: 10692051
[TBL] [Abstract][Full Text] [Related]
15. Despite increased CD4+Foxp3+ cells within the infection site, BALB/c IL-4 receptor-deficient mice reveal CD4+Foxp3-negative T cells as a source of IL-10 in Leishmania major susceptibility.
Nagase H; Jones KM; Anderson CF; Noben-Trauth N
J Immunol; 2007 Aug; 179(4):2435-44. PubMed ID: 17675505
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 2 is an Upstream Regulator of CD4+ T Cells From Visceral Leishmaniasis Patients With Therapeutic Potential.
Chauhan SB; Faleiro R; Kumar R; Ng S; Singh B; Singh OP; Singh SS; Amante F; Rivera FL; Rai M; Chakravarty J; Sacks D; Nylen S; Sundar S; Engwerda C
J Infect Dis; 2019 Jun; 220(1):163-173. PubMed ID: 30796820
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of IL-2 induced IL-10 production as a principle of phase-specific immunotherapy.
Bodas M; Jain N; Awasthi A; Martin S; Penke Loka RK; Dandekar D; Mitra D; Saha B
J Immunol; 2006 Oct; 177(7):4636-43. PubMed ID: 16982902
[TBL] [Abstract][Full Text] [Related]
18. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
[TBL] [Abstract][Full Text] [Related]
19. Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells.
Stäger S; Maroof A; Zubairi S; Sanos SL; Kopf M; Kaye PM
Eur J Immunol; 2006 Jul; 36(7):1764-71. PubMed ID: 16791879
[TBL] [Abstract][Full Text] [Related]
20. Enhanced lesional Foxp3 expression and peripheral anergic lymphocytes indicate a role for regulatory T cells in Indian post-kala-azar dermal leishmaniasis.
Ganguly S; Mukhopadhyay D; Das NK; Chaduvula M; Sadhu S; Chatterjee U; Rahman M; Goswami RP; Guha SK; Modak D; Mallik S; Gonju D; Pramanik N; Barbhuiya JN; Saha B; Chatterjee M
J Invest Dermatol; 2010 Apr; 130(4):1013-22. PubMed ID: 20032994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
